Mereo BioPharma Group plc financial data

Symbol
MREO on Nasdaq
Location
One Cavendish Place, Fourth Floor, London, United Kingdom
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 632 %
Debt-to-equity 21.1 %
Return On Equity -69.3 % -30.1%
Return On Assets -57.3 %
Operating Margin -3.92K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 795M shares +13.4%
Entity Public Float 471M USD +228%
Common Stock, Value, Issued 3.13M USD +12.9%
Weighted Average Number of Shares Outstanding, Basic 784M shares +12%
Weighted Average Number of Shares Outstanding, Diluted 784M shares +12%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 20.9M USD +29.6%
General and Administrative Expense 27.8M USD +55.5%
Operating Income (Loss) -48.7M USD -80.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -47.2M USD -75.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -47.2M USD -79.1%
Earnings Per Share, Basic 0 USD/shares -133%
Earnings Per Share, Diluted 0 USD/shares -133%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 62.5M USD +28.4%
Assets, Current 66.9M USD +25.1%
Property, Plant and Equipment, Net 247K USD -31.4%
Operating Lease, Right-of-Use Asset 622K USD -43.9%
Intangible Assets, Net (Excluding Goodwill) 1.09M USD
Assets 68.3M USD +22.1%
Accounts Payable, Current 2.92M USD +19.1%
Accrued Liabilities, Current 2.93M USD +15.5%
Liabilities, Current 7.5M USD -31.9%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 325K USD -36.6%
Liabilities 8.24M USD -37.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -15.3M USD +16.4%
Retained Earnings (Accumulated Deficit) -472M USD -10.1%
Stockholders' Equity Attributable to Parent 60.1M USD +40.3%
Liabilities and Equity 68.3M USD +22.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.33M USD -4.23%
Net Cash Provided by (Used in) Financing Activities 422K USD
Net Cash Provided by (Used in) Investing Activities -320K USD +54.3%
Common Stock, Shares, Issued 795M shares +13.4%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7K USD +75%
Deferred Tax Assets, Valuation Allowance 215M USD +4.21%
Deferred Tax Assets, Gross 215M USD +4.21%
Operating Lease, Liability 747K USD -46.2%
Depreciation 140K USD -17.6%
Payments to Acquire Property, Plant, and Equipment 20K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -44.2M USD -75.3%
Lessee, Operating Lease, Liability, to be Paid 790K USD
Property, Plant and Equipment, Gross 1.26M USD +5.6%
Operating Lease, Liability, Current 747K USD +12.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 118M USD +6.33%
Operating Lease, Payments 778K USD -2.75%
Additional Paid in Capital 544M USD +11.8%
Amortization of Intangible Assets 106K USD -1.85%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Operating Leases, Future Minimum Payments Due 1.54M USD
Interest Expense 1.24M USD -48.1%